Apolipoprotein E polymorphism in hemodialyzed patients and healthy controls

Area of Science:

• Genetics
• Nephrology
• Human Physiology

Background:

• Conflicting evidence exists regarding the association between apolipoprotein E (APOE) gene polymorphism and end-stage renal disease (ESRD).
• Understanding genetic predispositions is crucial for identifying individuals at risk for chronic kidney disease.

Purpose of the Study:

• To investigate the association between APOE genotypes and ESRD in a large cohort of Caucasian individuals.
• To determine if APOE alleles are risk factors for developing ESRD.

Main Methods:

• Case-control study involving 995 hemodialyzed patients (cases) and 6242 healthy controls from the Czech Republic.
• Analysis of APOE genotypes and allele frequencies in both patient and control groups.
• Statistical analysis to calculate odds ratios and confidence intervals for ESRD risk associated with APOE alleles.

Main Results:

• A statistically significant difference in APOE allele frequencies was observed between ESRD patients and controls.
• Carriers of the APOE2 allele were more prevalent in the ESRD group (15.9%) compared to controls (12.2%) (P = 0.005).
• The odds ratio for ESRD associated with the APOE2 allele was 1.37, with the risk increasing with longer duration of hemodialysis.

Conclusions:

• The APOE2 allele may represent a genetic risk factor for all-cause ESRD in Caucasian individuals.
• Further research is warranted to elucidate the mechanisms underlying this association.
• APOE genotyping could potentially aid in identifying individuals susceptible to ESRD.